20-Nov-2026 08:33:14

NATCOPHARMGeneral news

NATCO : RECEIVES EIR FROM US FDA FOR VISAKHAPATNAM FDF UNIT

• US FDA classified the August 2026 inspection of the Parawada, Visakhapatnam FDF plant as Voluntary Action Indicated (VAI) • Inspection was conducted from August 17 to August 21, 2026 • Company had received 4 observations in Form-483 at the conclusion of the inspection

Natco Pharma Limited

Open attachment

← Back to feed